(5-(2,6-Difluorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(4-methylpiperazin-1-yl)acetamide

ID: ALA4127204

PubChem CID: 53362014

Max Phase: Preclinical

Molecular Formula: C17H18F2N4O2S2

Molecular Weight: 412.49

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(NC(=O)CN2C(=O)/C(=C/c3c(F)cccc3F)SC2=S)CC1

Standard InChI:  InChI=1S/C17H18F2N4O2S2/c1-21-5-7-22(8-6-21)20-15(24)10-23-16(25)14(27-17(23)26)9-11-12(18)3-2-4-13(11)19/h2-4,9H,5-8,10H2,1H3,(H,20,24)/b14-9-

Standard InChI Key:  KKPROWUAHDQTCH-ZROIWOOFSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    7.3010  -12.9513    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.1182  -12.9513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3726  -12.1746    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7096  -11.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0509  -12.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7084  -10.8752    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5978  -13.6130    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.2736  -11.9224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6665  -12.4695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1501  -11.9231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3212  -11.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0987  -10.8726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7146  -10.5764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2697  -10.0735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0460   -9.8258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2182   -9.0306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6142   -8.4796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8352   -8.7295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6601   -9.5304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7882   -7.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8901  -12.2148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2834  -12.7611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4534  -13.5613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2355  -13.8123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8389  -13.2643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7213  -11.4153    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.6171  -13.5136    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  2  0
  2  7  2  0
  5  8  2  0
  8  9  1  0
  3 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
  9 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  9  1  0
 21 26  1  0
 25 27  1  0
M  END

Associated Targets(non-human)

blm Metallo-beta-lactamase type 2 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Bacterial beta-lactamase TEM (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaUOE-1 Beta-lactamase CTX-M (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Beta-lactamase OXA-10 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.49Molecular Weight (Monoisotopic): 412.0839AlogP: 1.44#Rotatable Bonds: 4
Polar Surface Area: 55.89Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.41CX Basic pKa: 6.97CX LogP: 1.64CX LogD: 1.50
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -2.02

References

1. Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ..  (2018)  Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases.,  26  (11): [PMID:29655609] [10.1016/j.bmc.2018.02.043]

Source